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This daily COVID-19 Health Evidence Summary is to signpost DFID and other UK government 
departments to the latest relevant evidence and discourse on COVID-19 to inform and support 
their response. It is a result of 3 hours of work and is not intended to be a comprehensive summary 
of available evidence on COVID-19 but aims to make original documents easily accessible to 
decision makers which, if relevant to them, they should go to before making decisions.   
 
Epidemiology and modelling  
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
06.07.2020 Prediction 
of 
COVID-
19 
spreading 
profiles in 
South 
Korea, 
Italy and 
Iran by 
data-
driven 
coding 
PLOS One 
 This work applies a data-driven 
coding method for prediction of 
the COVID-19 spreading profile 
in any given population that 
shows an initial phase of 
epidemic progression. 
 Application of the method to the 
data collected for South Korea, 
Italy and Iran shows that peaks 
of infection cases are expected 
to occur before mid April, the 
end of March and the end of 
May 2020, and that the 
percentage of population 
infected in each city or region 
will be less than 0.01%, 0.5% 
and 0.5%, for South Korea, 
Italy and Iran, respectively. 
  
Data 
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Infection Prevention and Control 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
  
06.07.2020 Global 
resource 
shortages 
during 
COVID-
19: Bad 
news for 
low-
income 
countries 
PLOS 
Neglected 
Tropical 
Diseases 
 To better elucidate COVID 
preparedness in low-income 
countries, we combined data 
from all service provision 
assessments (SPAs) 
conducted in nationally 
representative surveys of 
hospitals within the past 5 
years in low-income 
countries, which included 
Afghanistan, Democratic 
Republic of the Congo 
(DRC), Haiti, Nepal, and 
Tanzania. 
 Conclusions: Continued local 
as well as international 
action is needed to ensure 
access to PPE for all health 
workers and respiratory 
support for all patients, not 
just for those living in 
resource-abundant countries. 
As COVID-19 therapeutics 
and vaccines emerge, 
additional international 
commitment will be 
necessary to ensure global 
access. 
PPE 
  
06.07.2020 Mobility 
restrictions 
for the 
control of 
epidemics: 
When do 
they work? 
PLOS One 
 Mobility restrictions may not 
be an effective policy for 
controlling the spread of an 
infectious disease if it is 
assessed by the overall final 
epidemic size. Patterns of 
mobility established through 
the independent mobility and 
trade decisions of people in 
both communities may be 
sufficient to contain 
epidemics. 
Mobility 
restrictions 
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Therapeutics 
Publication 
date 
Title/URL Journal/Article 
type 
Summary             Keywords 
06.07.2020 The Role of 
Remdesivir 
in South 
Africa: 
Preventing 
COVID-19 
Deaths 
Through 
Increasing 
ICU Capacity 
Clinical 
Infectious 
Diseases 
 Countries such as South 
Africa have limited 
intensive care unit (ICU) 
capacity to handle the 
expected number of 
COVID-19 patients 
requiring ICU care. 
Remdesivir can prevent 
deaths in countries such as 
South Africa by decreasing 
the number of days people 
spend in ICU, therefore 
freeing up ICU bed 
capacity. 
 Remdesivir 
Indirect impact of COVID-19 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
18.06.2020 Pausing 
the Fight 
Against 
Malaria to 
Combat the 
COVID-19 
Pandemic 
in Africa: Is 
the Future 
of Malaria 
Bleak? 
Frontiers in 
microbiology 
 Access to healthcare has 
generally been limited by 
COVID-19, while malaria 
interventions, such as 
seasonal malaria 
chemotherapy and 
distribution of insecticide-
treated bed nets, have been 
suspended due to 
lockdowns.  
 Likewise, the repurposing of 
antimalarials for treatment of 
COVID-19 shared symptoms 
and the shift in focus from 
the production of malaria 
rapid diagnostic tests 
(RDTs) to COVID-19 RDTs 
is a cause for concern in 
malaria-endemic regions.  
 Children are less affected by 
the COVID-19 pandemic 
compared to the elderly. 
However, due to the fears of 
contracting SARS-CoV-2, 
the elderly who are worst 
affected by COVID-19 may 
not take children for malaria 
Malaria 
4 
medication, resulting in high 
malaria-related mortalities 
among children.  
02.07.2020 The Impact 
of COVID-
19 on 
People 
With 
Diabetes in 
Brazil 
Diabetes 
research and 
clinical 
practise 
 Convenience sampling study 
with data collected from 
1701 individuals. 
 Study provides a firsthand 
revelation of the severity of 
COVID-19 on individuals 
with diabetes in Brazil, 
altering their habits, which 
impacted their glycemia, 
potentially increasing their 
risk of poor outcomes if 
infected by SARS-CoV-2. 
Diabetes 
Comments, Editorials, Opinions, Blogs, News 
Publication 
date 
Title/URL Journal | Article type Author(s) 
June 2020 Cardiovascular care in sub-Saharan 
Africa during the COVID-19 crisis: 
lessons from the global experience 
Cardiovascular 
Journal of Africa | 
Editorial 
Kishal Lukhna, 
Blanche 
Cupido, Jens 
Hitzeroth, 
Ashley Chin, 
Mpiko Ntsekhe 
August 
2020 
COVID-19, health rights of prison staff, 
and the bridge between prison and 
public health in Africa 
Public Health | Letter M C Van Hout 
03.07.2020 Covid-19: No large hidden outbreak in 
Africa but health worker shortage 
worsens 
BMJ | News Owen Dyer 
03.07.2020 Remdesivir: US purchase of world 
stocks sparks new “hunger games,” 
warn observers 
BMJ | News Jacqui Wise 
06.07.2020 Reset Sustainable Development Goals 
for a pandemic world 
Nature | Comment   
06.07.2020 Cambodia’s Response to COVID-19 JHBSPH | Podcast Dr. Kumanan 
Rasanathan, 
5 
talks with Dr. 
Sara Bennett 
Dashboards & Trackers 
Cases & 
deaths: 
Global 
Cases & 
deaths: 
Regional 
Cases & 
deaths: 
Country 
Living 
evidence & 
policy maps 
Current 
research 
including trials 
  Diagnostics  Treatments   Vaccines 
WHO sitreps WHO 
Africa 
Ghana COVID-
NMA 
WHO   FIND 
SARS-CoV-
2 Test 
Tracker 
  Global 
COVID-19 
Clinical Trial 
Tracker 
  CEPI 
WHO 
dashboard 
African 
Arguments 
Indonesia EPPI 
Centre 
WHO 
International 
Clinical Trials 
Registry 
Platform 
(ICTRP) 
 FIND 
SARS-CoV-
2 
Diagnostics: 
performance 
data 
  US NIH 
registered 
clinical trials 
Vaccine 
Centre 
LSHTM 
Johns 
Hopkins 
University 
European 
CDC 
Nigeria 
CDC 
Norwegian 
Institute of 
Public 
Health 
Cytel  Serology-
based tests 
for COVID-
19 
  Solidarity 
trial 
 COVID-
19 Oxford 
Vaccine 
Trial 
WEF 
  Sierra 
Leone 
 Oxford C19 
Government 
Response 
Tracker 
(OxCGRT) 
US NIH  Our World 
in Data: C19 
Testing 
  COVID-19 
Therapeutics 
Accelerator 
 COVID-
19 
Vaccine 
Tracker 
Our World in 
Data 
  Singapore  Our World 
in Data: 
C19 Policy 
responses 
COVID-
evidence 
      
Global 5050 
  UK  IFPRI 
COVID-19 
Policy 
Response 
Portal 
Cochrane       
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CEBM, 
University of 
Oxford 
  US  COVID-19 
Primer 
Clinicaltrials.gov       
Humanitarian 
Data 
Exchange 
     NIH 
LitCovid 
 UKCDR       
Information 
is Beautiful 
     WHO 
COVID-19 
Database 
        
LSHTM               
HealthMap 
(cases) 
              
The 
Commons 
Project 
              
C19 Resource Hubs 
Global  Regional & 
Country 
Academic 
journals & 
Publishers 
Institutes/Centres
/Funders/Other 
Health 
Topics 
  Social 
Sciences 
WHO COVID-
19 pandemic  
Africa CDC Annals of 
Internal 
Medicine 
LSTM Stop TB 
Partnership 
  SSHAP 
WHO risk 
communication 
African 
Union 
BMJ LSHTM 
 
  IDA 
WHO Q&A Nigeria 
CDC 
Bulletin of 
the WHO 
ICL MRC Centre 
for Global 
Infectious 
Disease Analysis 
Global 
Menstrual 
Collective  
  Disability and 
inclusion 
7 
WHO Global 
research 
GeoPoll: 
SSA 
Cambridge 
University 
Press 
ODI SLH: 
Handwashin
g in low 
resource 
settings 
  Coregroup 
IDDC 
COVID-19 
Solidarity 
Response Fund 
Global 
Health 
Network 
Africa 
Cell Press Johns Hopkins 
University 
RBM 
Partnership 
  Ethics, health 
systems & 
COVID-19 
UN African 
Academy of 
Sciences 
Cochrane  Center for Global 
Development 
 Epidemic 
Preparedne
ss 
Innovations 
  Social 
Development 
Direct C19 
blog series 
UN Women Africa 
Evidence 
Network 
Elsevier CMMID 
Repository 
    
UNOCHA OCHA 
Southern 
and Eastern 
Africa 
COVID-19 
Digest 
Health 
Policy and 
Planning  
Norwegian 
Institute of Public 
Health 
    
UNHCR  South 
African 
Government 
JAMA 
Network 
Oxford Centre for 
Evidence-based 
Medicine 
    
UNICEF   The 
Lancet 
 HEART     
UNESCO   medRxiv 
and 
bioRxiv 
(Preprints) 
 UKRI     
UN WFP   NEJM  Evidence Aid     
8 
GOARN   Oxford 
University 
Press 
 NIH     
EPI-WIN   PLoS IFPRI Resources 
and Analyses of 
C19 Impact 
    
World Bank   SAGE 
journals 
 Prevent 
Epidemics  
    
Our World in 
Data 
  Science       
COVID-19 
Narratives by 
David Nabarro 
  Springer 
Nature 
      
Reliefweb   SSRN 
(Preprints)  
      
Humanitarian 
OpenStreetMap 
Team 
  Wiley       
Global 
Partnership for 
Sustainable 
Development 
Data 
  
 
      
WorldPop           
Flowminder           
COVID-END           
Premise 
COVID-19 
Global Impact 
Study 
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GISAID           
Online learning & events 
Date Title/URL Online 
learning/event 
Duration Lead 
07.07.2020 
1300-1430 
BST 
Fifth Annual Health 
Financing Forum 
(AHFF): Health 
Financing Resilience 
and Sustainability 
Online event 1h 30 JLN, WB, USAID, 
GFF, GFF, CGD 
30.06.2020 
1000 BST 
Clinical update: 
dexamethasone and 
hydroxychloroquine for 
treatment of severe 
COVID-19  
Webinar   African Academy of 
Sciences 
26.06.2020 
0900 to 
1030 EDT 
Monitoring and 
mitigating the collateral 
effects of COVID-19 
Online event 1h 30 CGD 
13 July 
3:00 PM – 
6:00 PM 
BST 
2020 UCL-Lancet 
Lecture: Global Health 
Preparedness by Dr 
Muhammad Pate, 
Global Director for 
Health, Nutrition and 
Population at the World 
Bank Group 
Online 
Lecture  
2 hour 
lecture, 1 
hour panel 
discussion 
UCL, The Lancet 
June 2020 OpenWHO, the free, 
open-access learning 
platform for health 
emergencies, now 
offers 10 online 
courses related to 
COVID19. 
Online 
courses 
Varies WHO 
24-
25.06.2020 
Africa’s leadership role 
in COVID-19 vaccine 
Zoom webinar   African Union & Africa 
CDC 
10 
development and 
access 
Available 
now 
Standard precautions: 
Environmental cleaning 
and disinfection 
Online course 1 hour WHO 
Available 
now 
COVID-19: Effective 
Nursing in Times of 
Crisis 
Online course 2 weeks – 2 
hours per 
week 
Johns Hopkins School 
of Nursing 
Available 
now 
WHO Academy and 
WHO Info mobile 
applications 
Mobile app   WHO 
Available 
now 
COVID-19: Pandemics, 
Modelling and Policy 
Online 
learning 
2 weeks | 2 
hours 
weekly 
study 
FutureLearn 
UNESCO UNITWIN 
Complex Systems 
Digital Campus/Open 
University 
12.05.2020 COVID-19 and 
maintaining quality 
essential health 
services  
Webinar 1 hour WHO & ISQua – Dr 
Shams Syed, Dr 
Peter Lachman, Dr 
Teri Rynolds & Dr Ed 
Kelley 
11.5.2020 COVID-19 Contact 
Tracing course 
Online 
learning 
5 hours Johns Hopkins 
Bloomberg School of 
Health 
7-28 May 
2020 
Virtual Evidence Weeks 5 sessions 1h 30 International Initiative 
for Impact Evaluation 
(3ie) 
Tuesdays 
at 1700 
CEST 
(Geneva 
time) & 
Thursdays 
0830 CEST 
(Geneva 
time) 
COVID-19 Open online 
brief with Dr David 
Nabarro 
Event 1h 4SD 
11 
30.04.2020 Professor Chris 
Whitty’s Gresham 
lecture on COVID-19 
Event 1h 20 Gresham College 
Available 
now 
Emerging respiratory 
viruses, including 
COVID-19: methods for 
detection, prevention, 
response and control 
Online 
learning 
3 hours WHO 
Available 
now 
Responding to COVID-
19: Real-time training 
for the coronavirus 
disease outbreak 
Online 
learning 
Multiple 
self-paced 
course 
WHO 
25 May 
2020 
COVID-19: Tackling the 
Novel Coronavirus 
Online 
learning 
3 weeks | 4 
hours 
weekly 
study 
FutureLearn 
LSHTM/UK PHRST 
Available 
online now 
without 
mentors. 
Updated 
version will 
commence 
early June 
2020 
COVID-19 Diagnostics 
and Testing 
Online 
learning 
3 weeks | 3 
hours 
weekly 
study 
FutureLearn 
FIND/LSHTM/ASLM 
6 April 2020 COVID-19 Critical 
Care: Understanding 
and Application 
Online 
learning 
5 weeks | 1 
hour weekly 
study 
FutureLearn 
University of 
Edinburgh & Royal 
College of Physicians 
of Edinburgh  
Available 
now 
COVID-19 supporting 
online courses 
Online 
learning 
Multiple 
self-paced 
course 
BMJ Learning 
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Rapid review methodology 
The rapid daily search for peer-reviewed literature is carried out through a PubMed search with the following 
keywords (“COVID-19” OR “severe acute respiratory syndrome coronavirus 2” OR “2019-nCoV” OR “SARS-CoV-
2” OR “2019nCoV” OR “coronavirus” ) AND (“Africa”) OR (“equity” OR “equities”) OR (“poverty”), restricted to 
articles published in the previous 2 to 3 days, in English. This is complemented by a search of the homepage of 
the following high-impact global health journals: The Lancet journals, New England Journal of Medicine, Nature, 
JAMA, Annals of Internal Medicine, Cochrane Reviews, BMJ Global Health, the PLoS journals and a Twitter 
search of their Twitter pages. A search also of preprints from bioRxiv and medRxiv. Please note that papers that 
have not been peer-reviewed are highlighted in red. All primary research papers that relate to the primary and 
secondary impacts of the COVID-19 response in LMICs, and disease control and health system responses are 
included. Articles related to tackling the secondary impacts on other sectors are not included. Additional 
commentaries, opinions, and commissioned pieces are selected based on relevance. 
The search for dashboards, guidelines, tools, editorials, comments, blogs, opinions and news is through the 
academic journals listed above, C19 resource hubs and following lead academics and professionals on Twitter. 
 
About this report 
This daily COVID-19 health evidence summary (HES) is based on 3 hours of desk-based research. The 
summary is not intended to be a comprehensive summary of available evidence on COVID-19 but aims to make 
original documents easily accessible to decision makers which, if relevant to them, they should go to before 
making decisions. The HES are not intended to replace medical or professional advice and the researcher or the 
K4D consortium cannot be held responsible for any decisions made about COVID-19 on the basis of the HES 
alone. K4D services are provided by a consortium of leading organisations working in international development, 
led by the Institute of Development Studies (IDS), with Education Development Trust, Itad, University of Leeds 
Nuffield Centre for International Health and Development, Liverpool School of Tropical Medicine (LSTM), 
University of Birmingham International Development Department (IDD) and the University of Manchester 
Humanitarian and Conflict Response Institute (HCRI). 
This evidence summary was prepared for the UK Government’s Department for 
International Development (DFID) and its partners in support of pro-poor programmes. 
It is licensed for non-commercial purposes only. K4D cannot be held responsible for 
errors, omissions or any consequences arising from the use of information contained in 
this health evidence summary. Any views and opinions expressed do not necessarily 
reflect those of DFID, K4D or any other contributing organisation.  
© DFID - Crown copyright 2020. 
 
